Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dow CEO says Manufacturing Renaissance is Within Reach

Published: Thursday, April 04, 2013
Last Updated: Thursday, April 04, 2013
Bookmark and Share
Andrew Liveris, chairman, and ceo of The Dow Chemical Company (Dow) has called upon chemical engineers to reclaim their mantle as the world’s biggest problem solvers.

But Liveris, who was speaking in London, UK last night, also warned that too many governments lack a coherent energy policy and were not working closely enough with industry or the public.

“Optimism is returning to the U.S. economy and it is because of the manufacturing sector,” said Liveris.

”In the UK, the manufacturing industry has remained somewhat insulated from the overall downturn and the downstream industry is well placed to be part of a global manufacturing renaissance.

“The chemical industry is at the vanguard of a manufacturing revolution, but we cannot work in a silo. Private and public sectors must work as equal partners to establish enduring frameworks that enable business to innovate solutions, create jobs, and generate growth for the long term – to collaborate across boundaries, across industries, across markets and value chains, across disciplines, across all discontinuities.”

He went on to dismiss debates over large or small governments, citing the need for ‘smart government’ regardless of size and warned that excessive regulation in order to attract and maintain inward investment was short-sighted.

“What we need now is innovation, new business models, a set of new and great solutions for daunting problems. We also need bold leaders, collaborating across outdated divisions between what is best for companies and what is best for countries,” said Liveris.

“We need leaders innovating new ways to make the world a healthier, more productive place for generations to come. That is how we manufacture a new foundation for economic growth and how we fuel the engines of economic growth at the same time.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos